Marjan Sepassi
![Marjan Sepassi Marjan Sepassi](https://www.als-drug-development.com/wp-content/uploads/sites/702/2024/01/marjan-150x150.png)
Company: Clene Nanomedicine
Job title: Vice President - Medical Affairs
Seminars:
Reinventing the Surrogate Landscape: Innovating Regulatory Acceptable Endpoints Most Meaningful to People Living with ALS 2:05 pm
The recent accelerated approval brings new waves of promise for transformative ALS drugs to be approved based on surrogate markers that correlate with ALSFRS-R. With increasing demand to define more acceptable endpoints for ALS, collaborate with industry sponsors and regulatory experts to: Evaluate the potential of novel surrogate biomarkers that extend beyond ALSFRS-R to monitor…Read more
day: Pre-Conference Day